AAAAAA

   
Results: 1-15 |
Results: 15
Usefulness of biochemical markers of bone turnover in assessing response to the treatment of Paget's disease
Authors: Alvarez, L Guanabens, N Peris, P Vidal, S Ros, I Monegal, A Bedini, JL Deulofeu, R Pons, F Munoz-Gomez, J Ballesta, AM
Citation: L. Alvarez et al., Usefulness of biochemical markers of bone turnover in assessing response to the treatment of Paget's disease, BONE, 29(5), 2001, pp. 447-452
Bone disease after liver transplantation: A long-term prospective study ofbone mass changes, hormonal status and histomorphometric characteristics
Authors: Monegal, A Navasa, M Guanabens, N Peris, P Pons, F de Osaba, MJM Ordi, J Rimola, A Rodes, J Munoz-Gomez, J
Citation: A. Monegal et al., Bone disease after liver transplantation: A long-term prospective study ofbone mass changes, hormonal status and histomorphometric characteristics, OSTEOPOR IN, 12(6), 2001, pp. 484-492
Collagen type I alpha I and vitamin D receptor gene polymorphisms and bonemass in primary biliary cirrhosis
Authors: Pares, A Guanabens, N Alvarez, L De Osaba, MJM Oriola, J Pons, F Caballeria, L Monegal, A Salvador, G Jo, J Peris, P Rivera, F Ballesta, AM Rodes, J
Citation: A. Pares et al., Collagen type I alpha I and vitamin D receptor gene polymorphisms and bonemass in primary biliary cirrhosis, HEPATOLOGY, 33(3), 2001, pp. 554-560
Bone mass and mineral metabolism in liver transplant patients treated withFK506 or cyclosporine A
Authors: Monegal, A Navasa, M Guanabens, N Peris, P Pons, F de Osaba, MJM Rimola, A Rodes, J Munoz-Gomez, J
Citation: A. Monegal et al., Bone mass and mineral metabolism in liver transplant patients treated withFK506 or cyclosporine A, CALCIF TIS, 68(2), 2001, pp. 83-86
Cyclical etidronate versus sodium fluoride in established postmenopausal osteoporosis: A randomized 3 year trial
Authors: Guanabens, N Farrerons, J Perez-Edo, L Monegal, A Renau, A Carbonell, J Roca, M Torra, M Pavesi, M
Citation: N. Guanabens et al., Cyclical etidronate versus sodium fluoride in established postmenopausal osteoporosis: A randomized 3 year trial, BONE, 27(1), 2000, pp. 123-128
Components of biological variation of biochemical markers of bone turnoverin Paget's bone disease
Authors: Alvarez, L Ricos, C Peris, P Guanabens, N Monegal, A Pons, F Ballesta, AM
Citation: L. Alvarez et al., Components of biological variation of biochemical markers of bone turnoverin Paget's bone disease, BONE, 26(6), 2000, pp. 571-576
Collagen type I alpha 1 gene polymorphism in idiopathic osteoporosis in men
Authors: Peris, P Alvarez, L Oriola, J Guanabens, N Monegal, A de Osaba, MJM Jo, J Pons, F Ballesta, AM Munoz-Gomez, J
Citation: P. Peris et al., Collagen type I alpha 1 gene polymorphism in idiopathic osteoporosis in men, RHEUMATOLOG, 39(11), 2000, pp. 1222-1225
Mutations in the gene encoding the latency-associated peptide of TGF-beta 1 cause Camurati-Engelmann disease
Authors: Janssens, K Gershoni-Baruch, R Guanabens, N Migone, N Ralston, S Bonduelle, M Lissens, W Van Maldergem, L Vanhoenacker, F Verbruggen, L Van Hul, W
Citation: K. Janssens et al., Mutations in the gene encoding the latency-associated peptide of TGF-beta 1 cause Camurati-Engelmann disease, NAT GENET, 26(3), 2000, pp. 273-275
Osteoporosis and solid organ transplantation
Authors: Guanabens, N
Citation: N. Guanabens, Osteoporosis and solid organ transplantation, MED CLIN, 114(20), 2000, pp. 772-773
Localisation of the gene causing diaphyseal dysplasia Camurati-Engelmann to chromosome 19q13
Authors: Janssens, K Gershoni-Baruch, R Van Hul, E Brik, R Guanabens, N Migone, N Verbruggen, LA Ralston, SH Bonduelle, M Van Maldergem, L Vanhoenacker, F Van Hul, W
Citation: K. Janssens et al., Localisation of the gene causing diaphyseal dysplasia Camurati-Engelmann to chromosome 19q13, J MED GENET, 37(4), 2000, pp. 245-249
Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy
Authors: Peris, P Alvarez, L Monegal, A Guanabens, N Duran, M Pons, F De Osaba, MJM Echevarria, M Ballesta, AM Munoz-Gomez, J
Citation: P. Peris et al., Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy, BONE, 25(3), 1999, pp. 349-353
High bilirubin levels interfere with serum tartrate-resistant acid phosphatase determination: Relevance as a marker of bone resorption in jaundiced patients
Authors: Alvarez, L Peris, P Bedini, JL Pares, A Monegal, A Guanabens, N Mas, E Aibar, C Ballesta, AM
Citation: L. Alvarez et al., High bilirubin levels interfere with serum tartrate-resistant acid phosphatase determination: Relevance as a marker of bone resorption in jaundiced patients, CALCIF TIS, 64(4), 1999, pp. 301-303
Quantitative evaluation of bone scintigraphy in the assessment of Paget's disease activity
Authors: Pons, F Alvarez, L Peris, P Guanabens, N Vidal-Sicart, S Monegal, A Pavia, J Ballesta, AM Munos-Gomez, J Herranz, R
Citation: F. Pons et al., Quantitative evaluation of bone scintigraphy in the assessment of Paget's disease activity, NUCL MED C, 20(6), 1999, pp. 525-528
Clinical usefulness of biochemical markers of bone turnover
Authors: Alvarez, L Guanabens, N Peris, P Ballesta, AM
Citation: L. Alvarez et al., Clinical usefulness of biochemical markers of bone turnover, MED CLIN, 112(13), 1999, pp. 517-518
Collagen type I alpha 1 gene Sp1 polymorphism in premenopausal women with primary osteoporosis: Improved detection of Sp1 binding site polymorphism in the collagen type 1 gene.
Authors: Alvarez, L Oriola, J Jo, J Ferro, T Pons, F Peris, P Guanabens, N Duran, M Monegal, A de Osaba, MJM Rivera-Fillat, F Ballesta, AM
Citation: L. Alvarez et al., Collagen type I alpha 1 gene Sp1 polymorphism in premenopausal women with primary osteoporosis: Improved detection of Sp1 binding site polymorphism in the collagen type 1 gene., CLIN CHEM, 45(6), 1999, pp. 904-906
Risultati: 1-15 |